secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001104659-23-019906
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics completes 1-for-20 reverse stock split; Nasdaq halt through Feb 14
--------------------------------------------------------------------------------

- Reverse stock split 1-for-20 effective 5:00 p.m. ET on Feb 10, 2023.
- Nasdaq halted trading in APRE at 7:50 p.m. Feb 10 pending material news related to split.
- Halt is administrative; trading expected to resume at 9:45 a.m. on Feb 14, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000110465923019906/0001104659-23-019906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000110465923019906/tm236659d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-019906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer